CDw75/ST6GAL1 Antibodies

Santa Cruz Biotechnology features a diverse variety of CDw75/ST6GAL1 monoclonal antibodies for research applications. CDw75/ST6GAL1 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDw75/ST6GAL1 is a sialyltransferase that plays a critical role in the biosynthesis of sialylated glycoproteins and glycolipids. CDw75/ST6GAL1 facilitates cell-cell interactions and influences various biological processes, including immune response and tumor progression. Understanding CDw75/ST6GAL1 function is crucial for elucidating its role in health and disease. Research has shown that CDw75/ST6GAL1 expression levels vary significantly across different tissue types and disease states. CDw75/ST6GAL1 has emerged as a potential therapeutic target in cancer research due to its involvement in tumor cell adhesion and metastasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CDw75/ST6GAL1's role in cellular processes and disease mechanisms.